reports
- Research Department
INFORME DIARIO 24 DICIEMBRE (ANÁLISIS BANCO SABADELL)
COMPAÑÍAS QUE APARECEN EN EL INFORME: ESPAÑA: ARCELOR MITTAL, ENDESA, ECOENER, SECTOR ELECTRICO ESPAÑA, OHLA. EUROPA: BASF Caídas moderadas en una sesión sin volumen y datos macro algo más flojos de fondo A pesar de la subida de EE.UU. el viernes después del cierre en Europa, en ausencia de más catalizadores, los peores datos macro publicados ayer en EE.UU, terminaron lastrando las bolsas europeas en una sesión con poco volumen. Así, en el STOXX 600, destacó al alza la subida de Farma gracias...
Nutriterra® Total Omega-3 Receives Health Canada Approval as Plant-Bas...
Nutriterra® Total Omega-3 Receives Health Canada Approval as Plant-Based Dietary Supplement WEST SACRAMENTO, Calif., Dec. 11, 2024 (GLOBE NEWSWIRE) -- Nutriterra® Total Omega-3 has received Health Canada approval as an ingredient in dietary supplements. Health Canada’s Natural and Non-prescription Health Products Directorate (NNHPD) issued a product license, Natural Product Number (NPN) 80136254, which authorizes it to be marketed and sold as a novel, canola-based total omega-3 oil with the following health claims: Supports heart health and cardiovascular functionSupports normal brain fu...
- Carole Braudeau
- Carole Braudeau
BASF SE: 1 director
A director at BASF SE bought 2,400 shares at 43.882EUR and the significance rating of the trade was 60/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly showin...
Element Solutions Inc to Participate in the UBS Global Technology and ...
MIAMI--(BUSINESS WIRE)-- Element Solutions Inc (NYSE:ESI) announced today that Benjamin Gliklich, Chief Executive Officer, will participate in a fireside chat at the UBS Global Technology and AI Conference in Scottsdale, AZ on Tuesday, December 3, 2024 at 7:35 a.m. MST. A live audio webcast of the discussion and replay will be made available in the Investors section of . About Element Solutions Inc Element Solutions Inc is a leading specialty chemicals company whose businesses supply a broad range of solutions that enhance the performance of products people use every day. Developed in mu...
- Emmanuel Matot
- Marc Lavaud
- Michael B. Schäfer
- Marc Lavaud
- Michael B. Schäfer
- Michael B. Schäfer
BASF : Feedback from mgmt. dinner - good October volumes, primarily in...
>Make or break € 8bn 2024 EBITDA guidance? 'Tight race', says mgmt; consensus already cautious at € 7.86bn, good 'Verbund' volume trends seen continuing in October - BASF hosted a sell-side/investors dinner with the executive board. BASF’s management confirmed a 'tight race' to make/break its FY 24 guidance, while the good volume trends seen primarily in the core 'Verbund' (Q3 24 +6.8% y-o-y vs 4.9% at group level) continued in October. The CEO indicated that this is ...
- Carole Braudeau
Credit Morning 11/20/2024
Grifols: the board considers that Brookfield’s indicative price undervalues the company Teva: S&P upgrades the rating to BB/positive from BB/positiveElior: Results recovered in 2023-24, exceeding expectations. Debt reduction is making headway as planned.Tereos: Sharp decline in EBITDA in Q2 24/25. The financial position is stable thanks to the generation of FCF.>...
- Carole Braudeau
Morning Crédit 20/11/2024
Grifols : le conseil d’administration estime que le prix indicatif proposé par Brookfield sous-évalue la sociétéTeva: S&P upgrades the rating to BB/positive from BB/positiveElior: les résultats se sont redressés 2023/24, dépassant les attentes. Le désendettement progresse comme prévu.Tereos : fort repli de l'EBITDA au T2 24/25. La situation financière est stable grâce à la génération de FCF.>...
Bayer AG: 1 director
A director at Bayer AG bought 11,278 shares at 20.745EUR and the significance rating of the trade was 73/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly show...
Element Solutions Inc Declares Q4 Dividend of $0.08 Per Share
MIAMI--(BUSINESS WIRE)-- Element Solutions Inc (NYSE: ESI) announced today that its board has declared a quarterly cash dividend of $0.08 per share of the company's common stock. The declared dividend will be paid on December 16, 2024 to stockholders of record as of the close of business on December 2, 2024. About Element Solutions Inc Element Solutions Inc is a leading specialty chemicals company whose businesses supply a broad range of solutions that enhance the performance of products people use every day. Developed in multi-step technological processes, these innovative solutions enabl...
Kerry Group: 1 director
A director at Kerry Group bought 1,310 shares at 92.200EUR and the significance rating of the trade was 62/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly sh...
- Christophe-Raphaël Ganet
- Marc Lavaud
- Martin Marandon-Carlhian
- Stephane Houri
- Christophe-Raphaël Ganet
- Marc Lavaud
- Martin Marandon-Carlhian
- Stephane Houri
- Michael B. Schäfer
- Stephan Wulf
Bayer : Weaker-than-expected Q3 results and cut in group’s adj. EBITDA...
>Group’s adj. EBITDA significantly below expectations - At a group level, Bayer’s Q3 sales of € 9.97bn (-3.6%), were below our (€ 10.2bn) and consensus estimates (€ 10.1bn), the group’s EBITDA of € 1,251m (-26%) came in 9% weaker than we expected (€ 1,376m) and was 5% below the consensus (€ 1,313m). The significant group’s EBITDA decline vs Q3 2023 was driven by the Pharma division, which came in at € 1,102m (23.4% below Q3 2023). Adjusted EPS of € 0.24 was 37% below ...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.